Comparison of patient reported dry eye symptoms as evaluated by the ocular surface disease index and symptom assessment

比较患者报告的干眼症状(通过眼表疾病指数和症状评估进行评估)

阅读:1

Abstract

BACKGROUND:  Dry eye disease (DED) is a growing public health problem because of excessive time spent on digital devices as a risk factor. The diagnosis of DED should not only be based on the objective clinical measures but also on symptoms reported by patients. Clinicians should not rely on establishing symptoms using open verbal questioning during the case history but should quantify patient symptoms using a validated questionnaire. AIM:  To compare the patient-reported symptoms of DED as assessed using the Ocular Surface Disease Index (OSDI) and Symptom Assessment in Dry Eye (SANDE). SETTING:  An optometry clinic. METHODS: Ocular Surface Disease Index and SANDE questionnaires were administered to 40 participants. Participants completed all questionnaires in a non-randomised order. The correlation between the questionnaires' scores was determined and the Bland-Altman plot was used to assess the agreement between the two questionnaires. RESULTS:  The mean scores for OSDI and SANDE were 37.85 ± 23.79 and 38.83 ± 26.39, respectively. The Spearman correlation between the two questionnaires was 0.7, p  0.01. The mean difference between OSDI and SANDE was -0.97 (95% Confidence Interval [CI]: [-7.04 to 5.09]). The Bland-Altman analysis between OSDI and SANDE showed a mean clinical difference (bias) of -0.98. CONCLUSION:  The SANDE questionnaire can be used as a dry eye symptom assessment as it is highly correlated to the OSDI questionnaire.Contribution: Because the OSDI and SANDE questionnaires showed a significant correlation and negligible score differences, this suggests that the SANDE questionnaire has the potential to provide clinicians with a short and quick measure of DED symptoms.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。